These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

225 related articles for article (PubMed ID: 34105011)

  • 1. [Inflammatory diseases of the central nervous system].
    Bachhuber A
    Radiologe; 2021 Jun; 61(6):575-585. PubMed ID: 34105011
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Comparative immunopathogenesis of acute disseminated encephalomyelitis, neuromyelitis optica, and multiple sclerosis.
    Wingerchuk DM; Lucchinetti CF
    Curr Opin Neurol; 2007 Jun; 20(3):343-50. PubMed ID: 17495631
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Brain and spinal cord lesion criteria distinguishes AQP4-positive neuromyelitis optica and MOG-positive disease from multiple sclerosis.
    Bensi C; Marrodan M; González A; Chertcoff A; Osa Sanz E; Chaves H; Schteinschnaider A; Correale J; Farez MF
    Mult Scler Relat Disord; 2018 Oct; 25():246-250. PubMed ID: 30144694
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Tumefactive Demyelinating Lesions in Multiple Sclerosis and Associated Disorders.
    Frederick MC; Cameron MH
    Curr Neurol Neurosci Rep; 2016 Mar; 16(3):26. PubMed ID: 26847090
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Classification and diagnostic criteria for demyelinating diseases of the central nervous system: Where do we stand today?
    Mathey G; Michaud M; Pittion-Vouyovitch S; Debouverie M
    Rev Neurol (Paris); 2018 Jun; 174(6):378-390. PubMed ID: 29673575
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Atypical Pediatric Demyelinating Diseases of the Central Nervous System.
    Troxell RM; Christy A
    Curr Neurol Neurosci Rep; 2019 Nov; 19(12):95. PubMed ID: 31773416
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Ferroptosis and central nervous system demyelinating diseases.
    Qin D; Li D; Wang C; Guo S
    J Neurochem; 2023 Jun; 165(6):759-771. PubMed ID: 37095635
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epidemiology, immunopathogenesis and management of pediatric central nervous system inflammatory demyelinating conditions.
    Pohl D
    Curr Opin Neurol; 2008 Jun; 21(3):366-72. PubMed ID: 18451724
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Imaging of Central Nervous System Demyelinating Disorders.
    Balashov K
    Continuum (Minneap Minn); 2016 Oct; 22(5, Neuroimaging):1613-1635. PubMed ID: 27740991
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Multiple Sclerosis and Autoimmune Neurology of the Central Nervous System.
    Galetta KM; Bhattacharyya S
    Med Clin North Am; 2019 Mar; 103(2):325-336. PubMed ID: 30704684
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Gastrointestinal dysfunction in neuroinflammatory diseases: Multiple sclerosis, neuromyelitis optica, acute autonomic ganglionopathy and related conditions.
    Sakakibara R
    Auton Neurosci; 2021 May; 232():102795. PubMed ID: 33740560
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Pediatric central nervous system inflammatory demyelination: acute disseminated encephalomyelitis, clinically isolated syndromes, neuromyelitis optica, and multiple sclerosis.
    Dale RC; Brilot F; Banwell B
    Curr Opin Neurol; 2009 Jun; 22(3):233-40. PubMed ID: 19434783
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Distinct brain imaging characteristics of autoantibody-mediated CNS conditions and multiple sclerosis.
    Jurynczyk M; Geraldes R; Probert F; Woodhall MR; Waters P; Tackley G; DeLuca G; Chandratre S; Leite MI; Vincent A; Palace J
    Brain; 2017 Mar; 140(3):617-627. PubMed ID: 28364548
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Neuropathology of Inflammatory and Autoimmune-Mediated Diseases].
    Takao M
    Brain Nerve; 2024 Apr; 76(4):353-360. PubMed ID: 38589280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Atypical inflammatory demyelinating syndromes of the CNS.
    Hardy TA; Reddel SW; Barnett MH; Palace J; Lucchinetti CF; Weinshenker BG
    Lancet Neurol; 2016 Aug; 15(9):967-981. PubMed ID: 27478954
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Pathological differences in acute inflammatory demyelinating diseases of the central nervous system.
    Wegner C
    Int MS J; 2005 Apr; 12(1):13-9, 12. PubMed ID: 15955274
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tumefactive demyelinating lesions as a first clinical event: Clinical, imaging, and follow-up observations.
    Jeong IH; Kim SH; Hyun JW; Joung A; Cho HJ; Kim HJ
    J Neurol Sci; 2015 Nov; 358(1-2):118-24. PubMed ID: 26333950
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Neuromyelitis Optica Spectrum Disorder and Other Non-Multiple Sclerosis Central Nervous System Inflammatory Diseases.
    Flanagan EP
    Continuum (Minneap Minn); 2019 Jun; 25(3):815-844. PubMed ID: 31162318
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Molecular pathology of multiple sclerosis and neuromyelitis optica].
    Masaki K
    Nihon Rinsho; 2014 Nov; 72(11):1909-17. PubMed ID: 25518370
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Imaging Differences between Neuromyelitis Optica Spectrum Disorders and Multiple Sclerosis: A Multi-Institutional Study in Japan.
    Tatekawa H; Sakamoto S; Hori M; Kaichi Y; Kunimatsu A; Akazawa K; Miyasaka T; Oba H; Okubo T; Hasuo K; Yamada K; Taoka T; Doishita S; Shimono T; Miki Y
    AJNR Am J Neuroradiol; 2018 Jul; 39(7):1239-1247. PubMed ID: 29724765
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 12.